The COVID-19 vaccine developed by Gamalei Institute of Epidemiology and Microbiology has successfully completed the Human Clinical Trials. The institute belongs to which country?

The COVID-19 vaccine developed by Gamalei Institute of Epidemiology an

1.	The COVID-19 vaccine developed by Gamalei Institute of Epidemiology and Microbiology has successfully completed the Human Clinical Trials. The institute belongs to which country?
Answer» The COVID-19 vaccine developed by Russia's Gamalei Institute of Epidemiology and Microbiology has successfully completed the Human Clinical Trials. The trials on volunteers were conducted from 18th June 2020 at Sechenov First Moscow State Medical University.